| Heineken buys Mexican breweryCNN - 1 hour agoNEW YORK (CNNMoney.com) -- Heineken announced plans Monday to buy the beer operations of Mexico's Fomento Econ?mico Mexicano (Femsa) for about $7.6 billion, as the Dutch brewer moves to expand its operations in the Western Hemisphere. The deal will give Heineken, which brews Amstel and other beers, control of Femsa's key export brands, including Dos Equis, Tecate and Sol. FACTBOX-Some facts about Mexican drinks maker FEMSA Reuters Gasoline prices zip toward $3 markDenver Post - 1 hour agoIn this Jan. 5, 2010 photo, Kevin Richards of Norton & Haines Hauling, puts away a fuel hose after topping off about 30,000 gallons of home heating oil into the underground storage tanks at Gleason's oil depot in Framingham, Mass. Oil prices jumped above $83 a barrel Monday, Jan. 11, amid signs of strong Chinese demand for crude, a weakening U.S. dollar and a strong flow of speculative funds into commodities. Gasoline prices on Monday continued their push toward $3 per gallon. Gas prices near $3 a gallon CNN Arabtec's Aabar Deal May Signal Looming LossesNew York Times - 7 hours agoArabtec Holding , based in Dubai, may need a $1.7 billion investment by Abu Dhabi’s Aabar Investments to cope with future losses, analysts said on Sunday, as the construction company’s shares fell 6.9 percent. On Friday, investment firm Aabar, 71 percent owned by the U.A.E. federal government, offered to buy a 70 percent stake in Arabtec through a convertible bond at 2.3 dirhams per share, in a deal valued at $1.7 billion. Arabtec's Aabar deal may signal looming losses Reuters | |
| |
UPDATE 1-Teva sees revenue more than doubling by 2015Reuters - 3 days agoNEW YORK, Jan 7 (Reuters) - Teva Pharmaceutical Industries Ltd ( TEVA.TA ), the world's largest generic drugmaker, on Thursday set a target of revenue of $31 billion in 2015, more than double its current annual amount as it sees major growth in overall use of generics. The Israel-based company also sees its more profitable branded business more than doubling over that time, as it reduces its dependence on its biggest-selling drug, the Copaxone multiple sclerosis treatment. Israel Stocks: Israel stocks off; Teva, energy firms in focus MarketWatch |
| |
|